Original Article Molecular and Clinical Analysis in a Series of Patients with Pyknodysostosis Reveals Some Uncommon Phenotypic Findings

Total Page:16

File Type:pdf, Size:1020Kb

Original Article Molecular and Clinical Analysis in a Series of Patients with Pyknodysostosis Reveals Some Uncommon Phenotypic Findings Int J Clin Exp Med 2014;7(11):3915-3923 www.ijcem.com /ISSN:1940-5901/IJCEM0002218 Original Article Molecular and clinical analysis in a series of patients with Pyknodysostosis reveals some uncommon phenotypic findings Margarita Valdes-Flores1, Alberto Hidalgo-Bravo1, L Casas-Avila1, Carmen Chima-Galan2, Eric J Hazan-Lasri1, Ernesto Pineda-Gomez1, Druso Lopez-Estrada1, Juan C Zenteno3 1Department of Genetics, National Institute of Rehabilitation, Mexico City, Mexico; 2Department of Genomic Medicine, National Medical Center 20th of November, ISSSTE, Mexico City, Mexico; 3Department of Biochemis- try, Faculty of Medicine, UNAM and Department of Genetics, Institute of Ophthalmology “Conde de Valenciana”, Mexico City, Mexico Received September 1, 2014; Accepted October 23, 2014; Epub November 15, 2014; Published November 30, 2014 Abstract: Pyknodysostosis is a rare autosomal recessive skeletal dysplasia characterized by short stature, deformity of the skull, osteosclerosis, hypoplasia of the clavicle, and bone fragility. Radiographs show increased bone density, osteosclerosis, and acroosteolysis of the terminal phalanges. The pycnodysostosis gene is located on chromosome 1q21 and encodes an enzyme called Cathepsin K. Cathepsin K is a cysteine protease lysosomal protein associated with the degradation of bone and cartilage. In the current study, the authors described the clinical, radiological and molecular features of a group of six Mexican patients, including two familial and two sporadic cases, with Pyknodys- ostosis. One of the patients presented hypoacusia, an unusual finding in this disease. Keywords: Pyknodysostosis, sclerosing, bone, dysplasia, Cathepsin K Introduction are abbreviated [6, 8, 9]. Short stature is an essential feature of the disease and it could be Pyknodysostosis is a rare autosomal recessive attributed not only to the sclerosing bone dys- skeletal dysplasia with complete penetrance plasia affecting long bones and vertebral col- [1]. To date, less than 200 patients have been umn, but also to associated anomalies such as reported in the literature. The estimated fre- congenital cardiopathy or malnutrition [10]. In quency is 1 to 1.7 per million. Both genders are addition, Soliman et al reported deficient growth affected equally and consanguinity has been hormone secretion in five of six patients with reported in about approximately 30% of the Pyknodysostosis in response to stimulation and cases [2]. The clinical manifestations were low IGF-1 concentration [10]. The physiologic described independently in 1962 by Maroteaux replacement with this hormone increased IGF-1 and Lamy [3] and by Andren et al [2]. The French concentration and improved linear growth in painter Henri de Tolouse Lautrec was retro- patients with Pyknodysostosis [6, 10]. Differ- spectively diagnosed with this disorder, howev- ential diagnosis includes osteopetrosis, acroos- er this has been subject of recent debate [4, 5]. teolysis, cleidocranial dysplasia, and mandibu- The principal clinical features of the disease loacral dysplasia [11]. are short stature, acroosteolysis of all distal phalanges, and bone fragility with frequent Linkage analysis in inbred Arab and Mexican fractures [6, 7]. Other features include delayed kindred previously showed that the Pykn- suture closure with skull deformities, promi- odysostosis locus was located on 1q21, a posi- nent nose, delayed teeth eruption, partial ano- tion from which the gene responsible of the dis- dontia, dental infections and short ramous of ease was subsequently cloned [12, 13]. The the mandible. Occasionally, exophthalmos and Pyknodysostosis gene, called Cathepsin K blue sclera are present. The trunk is not short- (CTSK), was originally cloned in osteoclasts ened although the metatarsals occasionally from rabbits and subsequently in several Uncommon features in Pyknodysostosis Table 1. Mutations described in the CTSK gene in patients with Pyknodysostosis. Taken from Xue et al. Orphanet J Rare Dis. 2011, 6: 20 and completed with data from Matsushita et al. Mol Syndromol 2011, 2: 254-258 and Zheng et al. Gene 2013, 521: 176-179 Genomic DNA Location Location in DNA Coding DNA Effect on First description sequence in protein sequence sequence amino acid variants variants sequence Missense Exon 2 g.1551T > C c.20T > C p.Leu7Pro Pre Donnarumma, et al., 2007 Exon 2 g.1557T > C c.26T > C p.Leu9Pro Pre Nishi, et al., 1999 Exon 3 g.2128C > T c.136C > T p.Arg46Trp Pro Schilling, et al., 2007 Exon 3 g.2227G > A c.235G > A p.Gly79Arg Pro Fratzl-Zelman, et al., 2004 Exon 3 g.2228G > A c.236G > A p.Gly79Glu Pro Hou, et al., 1999 Exon 4 g.2547G > A c.365G > A p.Arg122Gln Mature Zheng et al, 2013 Exon 4 g.2547G > C c.365G > C p.Arg122Pro Mature Matsushita et al, 2012 Exon 5 g.4120C > T c.422C > T p.Ala141 Val Mature Chavassieux, et al., 2008 Exon 5 g.4134G > C c.436G > C p.Gly146Arg Mature Gelb, et al., 1996 Exon 5 g.4192A > G c.494A > G p.Gln165Arg Mature Donnarumma, et al., 2007 Exon 5 g.4258A > C c.560A > C p.Gln187Pro Mature Li, et al., 2009 Exon 5 g.4278G > A c.580G > A p.Gly194Ser Mature Donnarumma, et al., 2007 Exon 6 g.8644A > G c.635A > G p.Tyr212Cys Mature Hou, et al., 1999 Exon 6 g.8737 G > A c.728G > A p.Gly243Glu Mature Khan et al., 2010 Exon 6 g.8755T > C c.746T > C p.Ile249Thr Mature Donnarumma, et al., 2007 Exon 6 g.8758A > G c.749A > G p.Asp250Gly Mature Donnarumma, et al., 2007 Exon 7 g.9109C > T c.830C > T pAla277Val Mature Gelb, et al., 1998 Exon 7 g.9109C > A c.830C > A p.Ala277Glu Mature Hou, et al., 1999 Exon 7 g.9171T > C c.892T > C p.Trp298Arg Mature Nishi, et al., 1999 Exon 8 g.9186G > A c.908G > A p.Gly303Glu Mature Toral-Lopez et al., 2010 Exon 8 g.11474T > C c.926T > C p.Leu309Pro Mature Haagerup, et al., 2000 Exon 8 g.11479G > C c.931G > C p.Ala311Pro Mature Nishi, et al., 1999 Exon 8 g.11482C > G c.934C > G p.Arg312Gly Mature Hou, et al., 1999 Exon 8 g.11501G > A c.953G > A p.Cys318Tyr Mature Bertola et al., 2010 Exon 8 g.11503G > T c.955G > T p.Gly319Cys Mature Donnarumma, et al., 2007 Nonsense Exon 3 g.2146A > T c.154A > T p.Lys52X Pro Hou, et al., 1999 Exon 5 g.4266C > T c.568C > T p.Gln190X Mature Hou, et al., 1999 Exon 6 g.8730C > T c.721C > T p.Arg241X Mature Gelb, et al., 1996 Frameshifts (duplication) Exon 2 g.1591-1592 dupGA c.60_61dupGA p.Ile21ArgfsX29 Pro Donnarumma, et al., 2007 Exon 4 g.2359 dupA c.282dupA p.Val95SerfsX9 Pro Donnarumma, et al., 2007 Frameshifts (deletion) Exon 3 g.2230delG c.238delG p.Asp80ThrfsX2 Pro Fratzl-Zelman, et al., 2004 Exon 5 g.4124delT c.426delT pPhe142LeufsX19 Mature Fujita, et al., 2000 Splicing Intron2 g.2112G > A c.121-1G > A p.del41Val-81Me Pro Haagerup, et al., 2000 Exon 7 g.9169G > A c.890G > A; 785_890de p.Gly262AlafsX70 Mature Donnarumma, et al.2007 Stop codon Exon 8 g.11538A > G c.990A > G p.X330TrpextX19 Mature Gelb. et.al., 1996 human tissues [13]. It is highly expressed in published in 2011, 33 mutations in the CTSK osteoclasts, osteoarthritic hipbones, and os- gene had been reported in patients with teoclastoma. Targeted mutation of the Cath- Pyknodysostosis [14], afterwards only two epsin K gene in mice resulted in many of the more mutations have been reported [15, 16] phenotypic features of Pyknodysostosis, includ- (Table 1). CTSK is a lysosomal cysteine prote- ing increased bone density and bone deformi- ase that is synthesized as a prepropeptid of 37 ties [4, 5, 13]. Subsequently, point mutations in kDa. The mature enzyme is a monomeric pro- the CTSK gene were detected in patients with tein of approximately 29 kDa. CTSK efficiently Pyknodysostosis [5]. In the review by Xu et al, cleaves peptide bonds in different proteins 3916 Int J Clin Exp Med 2014;7(11):3915-3923 Uncommon features in Pyknodysostosis Figure 1. Pedigrees of the two families with pyknodysostosis. A: Consanguinity is present in family A. B: In family B there is no documented evidence of consanguinity. Squares represent males; circles represent females; filled symbols are individuals with Pyknodysostosis; the arrow indicates the propositus (patient) in each family. Roman numerals on the left indicate each generation. Numbers above the symbols identify each individual. Numbers below indicate the age in years. including elastin and type I collagen, it is secret- Patient data ed to the sub-osteoclastic space where partici- pates in bone matrix degradation [17]. In the All patients were referred to the authors’ insti- current study the authors described the clini- tutions due to dysmorphic features. All were cal, radiological and molecular features of six Mexican mestizos and their ages ranged from 8 previously unreported Mexican patients (includ- to 53 years. The patients were informed about ing two familial and two sporadic cases) with the details and aims of the study and they Pyknodysostosis. agreed to participate by signing an informed 3917 Int J Clin Exp Med 2014;7(11):3915-3923 Uncommon features in Pyknodysostosis Table 2. Summary of the clinical and radiological features found in this series of patients Clinical Features Patient 1 Patient 2 Patient 3A Patient 3B Patient 4A Patient 4B Gender Male Female Female Female Female Female Age (years) 53 40 26 9 14 8 Presentation Sporadic Sporadic Familial Familial Familial Familial Parental consanguinity confirmed No No Yes Yes No No Height 1.53 m 1. 50 m 1.30 m 95 cm 1.27 m 97 cm Frequent fractures Yes Yes Yes No No No Increased bone density + + + + + + Frontal bossing + + + + + + Delayed suture closed + + + + + + Hypoplasia of the mandible + + + + + + Proptosis + + + + + + Blue sclera + + + + + + Prominent nose + + + + + + Delayed teeth eruption + + + + + + Malapposed teeth + + + + + + Enamel hypoplasia + + + + + + Clavicular dysplasia + + - - - - Short fingers (hands and feet) + + + + + + Acroosteolysis (distal phalanges) + + + + + + Dystrophic nails + + + + + + Conductive hypoacusia - - - - + - Methods Molecular analysis The study’s procedures were approved by the Institutional Review Board and informed con- sent form was obtained from each patient.
Recommended publications
  • A Comparative Study of Pycnodysostosis, Cleidocranial Dysostosis, Osteopetrosis and Acro-Osteolysis
    18 Mei 1974 S.-A. MEDIESE TYDSKRIF 1011 A Comparative Study of Pycnodysostosis, Cleidocranial Dysostosis, Osteopetrosis and Acro-osteolysis A. WOLPOWITZ, A. MATISONN SUMMARY thalmos, and blue sclerae have been noted. There may be a high, grooved palate. Platybasia may be found. There are A radiological study of cases of pycnodysostosis, osteo­ often poor dental formation and dental caries. Madelung's petrosis, cleidocranial dysostosis and acro-osteolysis type of deformity has been reported. revealed an interwoven relationship as regards the X-ray Laboratory findings are usually normal but reduced findings with numerous identical signs that these condi­ alkaline phosphatase values and slight hypercalcaemia tions had in common. Open fontanelles and sutures as have been reported. In recent reports cases with anaemia, well as metopic sutures were found in all 4 conditions; thrombocytopenia and splenomegaly were described."'· wormian bones, diminution or complete loss of mandibular angles, and hypoplastic paranasal sinuses and facial bones were noted in cleidocranial dysostosis, pycnodysostosis Radiological Findings and acro-osteolysis. Undertubulation of .Iong bones is seen in cleidocranial dysostosis and osteopetrosis. Osteo­ The most striking radiological finding is increased den­ petrosis and pycnodysostosis show sclerosis of bone, sity of bone. In spite of the bone sclerosis the medullary dense orbital margins, fractures after minimal trauma with canals are evident and the tubular bones are usually more abundant callus and rapid healing in common, while there delicate in calibre than normal, but normal in shape. is absorption of terminal phalanges and disturbance in There has, however, been a report of a case with splaying the development of the teeth in both pycnodysostosis and of the metaphyseal ends.' acro-osteolysis.
    [Show full text]
  • Pycnodysostosis with a Cathepsin K Mutation: a Case Report
    Ada Medica et Biologica Vol. 49, No.l, 31-37, 2001 Pycnodysostosis with a Cathepsin K Mutation: A Case Report Hiroshi YAMAGIWA1, Mayumi ASAOKA2, Hisayoshi KATO2, Minoru SHIBATA3, and Naoto ENDO1 'Department of Orthopedic Surgery, "Rehabilitation, and 3Plastic Surgery, Niigata University School of Medicine, Niigata, Japan Received October 16 2000 ; accepted January 22 2001 Summary.Pycnodysostosis (PKND) is a type of osteo- the distal phalanges, frequent fractures, and skull sclerosing bone disease. Recent studies have demon- deformities with delayed suture closure4'5'. The cathe- strated that several cathepsin K mutations can be psin K gene, which wa cloned originally from rabbit identified in PKND families. A fifty-three-year-old Japanese womandiagnosed with PKND with typical osteoclasts6', was highly expressed in osteoclasts. features suffered from the nonunion of the right tibial This molecule plays an important role in bone resorp- shaft. We did open reduction and performed a vascular- tion and remodeling. Cathepsin K knockout mice ized fibular graft using an external fixator. A low- show impaired osteoclastic bone resorption, which intensity pulsed ultrasound device was used three leads to osteopetrosis7'8). Recent studies have demon- months after surgery. Union of the tibia was completed strated several mutations in patients with about one year after surgery. Histomorphometric anal- PKND1'9-10'11'. In this paper, we present a clinical, ysis of the iliac bone revealed that the patient had low histomorphometric, and genomic study of a patient turnover bone with increased bone volume. Analysis of with the typical form of pycnodysostosis. Since the cathepsin K coding region from the genomic DNA parental consanguinity has been noted in more than of the patient and her family (consanguineous parents 30% of cases, we also analyzed her consanguineous and three sisters who were all of normal stature) revealed that the patient had a deletion of genomic parents and three sisters.
    [Show full text]
  • Distal Humerus Nonunion After Failed Internal Fixation: Reconstruction with Total Elbow Arthroplasty Dawn M
    (aspects of trauma • an original study) Distal Humerus Nonunion After Failed Internal Fixation: Reconstruction With Total Elbow Arthroplasty Dawn M. LaPorte, MD, Michael S. Murphy, MD, and J. Russell Moore, MD ABSTRACT onunion occurs in 2% ing treatment option. In the 1980s, In nonunion after distal humerus to 5% of distal humerus TEA for nonunion with tightly con- fracture, osteoporosis, devas- fractures.1 The condition strained or custom prostheses had cularized fracture fragments, is difficult to treat, and fair to moderately good results but and periarticular fibrosis limit Nno single treatment modality has a high complication rates (4/7, 57%6; potential reconstructive options. high success rate with few compli- 5/14, 36%10). According to a recent We assessed pain relief, func- 2-6 11 tional gains, and complications cations. Without intervention, the review, however, 31 (86%) of 36 in 12 patients whose long-stand- patient is left with a painful, unstable, patients had a satisfactory result with ing, painful nonunions after previ- and often flail extremity and with a semiconstrained prosthesis, and ous treatment with rigid internal limitations in activities of daily liv- only 7 (19%) of the 36 patients had fixation were reconstructed with ing. Frequently, there is an associ- complications. a semiconstrained total elbow ated ulnar neuropathy. Osteoporosis, In the current study, we assessed arthroplasty, frequently with a devascularized fracture fragments, outcomes (complications, symptoms, triceps-sparing approach and and periarticular fibrosis limit poten- function) after semiconstrained anterior ulnar nerve transposition. tial reconstructive options for long- TEA for long-standing distal humer- At mean follow-up of 63 months, 11 patients had good pain relief and standing distal humerus nonunions.
    [Show full text]
  • Nonunion with Bone Loss
    Nonunion with Bone Loss Tim Weber, MD Jeff Anglen, MD, FACS Original Authors; March 2004; Revised June 2006 and 2010 Etiology • Open fracture – segmental – post debridement – blast injury • Infection • Tumor resection • Osteonecrosis Classification Salai et al. Arch Orthop Trauma Surg 119 Classification Not Widely Used Not Validated Not Predictive Salai et al. Arch Orthop Trauma Surg 119 Evaluation • Soft tissue envelope • Infection • Joint contracture and range of motion • Nerve function: sensation, motor • Vasculature: perfusion, angiogram? • Location and size of defect • Hardware • General health of the host • Psychosocial resources Is it Salvageable? • Vascularity - warm ischemia time • Intact sensation or tibial nerve transection • other injuries • Host health • magnitude of reconstructive effort vs patient’s tolerance • ultimate functional outcome Priorities • Resuscitate • Restore blood supply • Remove dead or infected tissue (Adequate debridement) • Restore soft tissue envelope integrity • Restore skeletal stability • Rehabilitation Bone Loss - Initial Treatment • Irrigation and Debridement Bone Loss - Initial Treatment • Irrigation and Debridement • External fixation Bone Loss - Initial Treatment • Irrigation and Debridement • External fixation • Antibiotic bead spacers Bone Loss - Initial Treatment • ANTIBIOTIC BEAD POUCH – ANTIBIOTIC IMPREGNATED METHYL- METHACRALATE BEADS – SEALED WITH IOBAN Bone Loss - Initial Treatment • Irrigation and Debridement • External fixation • Antibiotic block spacers Beads Block Bone Loss - Initial
    [Show full text]
  • Blueprint Genetics Comprehensive Skeletal Dysplasias and Disorders
    Comprehensive Skeletal Dysplasias and Disorders Panel Test code: MA3301 Is a 251 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of disorders involving the skeletal system. About Comprehensive Skeletal Dysplasias and Disorders This panel covers a broad spectrum of skeletal disorders including common and rare skeletal dysplasias (eg. achondroplasia, COL2A1 related dysplasias, diastrophic dysplasia, various types of spondylo-metaphyseal dysplasias), various ciliopathies with skeletal involvement (eg. short rib-polydactylies, asphyxiating thoracic dysplasia dysplasias and Ellis-van Creveld syndrome), various subtypes of osteogenesis imperfecta, campomelic dysplasia, slender bone dysplasias, dysplasias with multiple joint dislocations, chondrodysplasia punctata group of disorders, neonatal osteosclerotic dysplasias, osteopetrosis and related disorders, abnormal mineralization group of disorders (eg hypopohosphatasia), osteolysis group of disorders, disorders with disorganized development of skeletal components, overgrowth syndromes with skeletal involvement, craniosynostosis syndromes, dysostoses with predominant craniofacial involvement, dysostoses with predominant vertebral involvement, patellar dysostoses, brachydactylies, some disorders with limb hypoplasia-reduction defects, ectrodactyly with and without other manifestations, polydactyly-syndactyly-triphalangism group of disorders, and disorders with defects in joint formation and synostoses. Availability 4 weeks Gene Set Description
    [Show full text]
  • Bone Marrow Injection for Treatment of Aneurysmal Bone Cyst
    MOJ Orthopedics & Rheumatology Bone Marrow Injection for Treatment of Aneurysmal Bone Cyst Research Article Abstract Volume 5 Issue 3 - 2016 Study design: Patients had Aneurysmal bone cyst lesion that underwent to be treated by Injection of Autologous Bone Marrow Aspirates (ABM) and follow up of this case for the final results. Patients and Methods: Sixteen patients had had Aneurysmal bone cyst had been treated by ABM injections. Study have 16 patients 11 females (68.75 %) and 5 Department of Orthopedics, Faculty of Medicine, Egypt Mahmoud I Abdel-Ghany, Assistant male (31.25 %). Age ranged from 3-14 years with average age 7.5 years. Number *Corresponding author: study including 5 cases (31.25 %) with proximal femoral cyst, 9 cases (56.25 %) Professor of Orthopedic and Trauma Surgery Faculty of of injections for every patient ranged from 2-6 times with average 4.4 times. This had tibial cyst (2 distal and 7 proximal tibiea) and 2 cases (12.5 %) had proximal Medicine for Girls, Egypt, Email: humeral cyst. All patients treated by injection of Autologous Bone Marrow Aspirates which obtained from the iliac crest. The bone marrow aspirates was Received: February 26, 2016 | Published: July 29, 2016 obtained percutaneous by bone marrow aspiration needle, According to follow up X-ray during injections we decide continuity of injections. Average size of the defect was 2.3 cm. and average amount bone marrow/inj. Was 10.2 cc. Results: Pain Score according to VAS ranged from 3-9 with average 5.7 which was improved to average 1.5 at final follow up.
    [Show full text]
  • Brown Tumour in the Cervical Spine : Case Report and Review of Literature
    http://crcp.sciedupress.com Case Reports in Clinical Pathology 2019, Vol. 6, No. 1 CASE REPORT Brown tumour in the cervical spine : Case report and review of literature S Carta1, A Chungh1, SR Gowda∗1, E Synodinou2, PS Sauve1, JR Harvey1 1Department of Trauma and Orthopaedics, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, UK 2Wessex Kidney Centre, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, UK Received: September 16, 2019 Accepted: October 18, 2019 Online Published: October 30, 2019 DOI: 10.5430/crcp.v6n1p27 URL: https://doi.org/10.5430/crcp.v6n1p27 ABSTRACT Background: Brown tumour of the cervical spine is very rare and is formed due to focal altered bone remodelling secondary to persistent and uncontrolled primary or secondary hyperparathyroidism. It is considered an extreme form of osteitis fibrosa cystica that occurs in the settings of persistently elevated parathyroid hormone. Case Report: This a unique lesion presented in a 48 year old male with recurrent bone pain and known End Stage Renal Disease (ESRD) on maintenance haemodialysis. The main clinical complaints were weak and painful legs and the initial presentation was after the patient collapsed at home and fractured spinal level C2. The initial assessment included blood tests and radiological imaging. CT scanning of the spine revealed a destructive lytic lesion with loss of height and architectural changes of the C2 vertebral body and cord compression. The differentials included an acute fracture, a metastatic lesion and Brown’s tumour. Further imaging with an MRI of the spine and PET-CT were performed which confirmed the above lesion and excluded metastatic disease and bone marrow infiltration.
    [Show full text]
  • Two Cases with Pycnodysostosis in a Family: a Case Report
    International Journal of Contemporary Pediatrics Reddy KV et al. Int J Contemp Pediatr. 2020 Jun;7(6):1441-1443 http://www.ijpediatrics.com pISSN 2349-3283 | eISSN 2349-3291 DOI: http://dx.doi.org/10.18203 /2349-3291.ijcp20202164 Case Report Two cases with pycnodysostosis in a family: a case report K. Venkataramana Reddy1*, Chapay Soren1, M. Geethika2, V. Malathi1 1Department of Pediatrics, 2Department of Radiodiagnosis, SVS Medical College, Mahabubnagar, Telangana, India Received: 06 February 2020 Revised: 28 April 2020 Accepted: 05 May 2020 *Correspondence: Dr. K. Venkataramana Reddy, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Pycnodysostosis (Greek, pycnos - density, dys - defect, ostosis - bone) is a rare inherited disorder of the bone, first described by Maroteaux and Lamy. Pycnodysostosis is an autosomal recessive disorder, with incidence estimated to be 1.7 per 1 million births. Clinical presentation of this disorder include short stature, dolichocephalic skull, frontal bossing, obtuse mandibular angle, dysplastic clavicles, and short hands and feet, diffuse osteosclerosis, acro- osteolysis along with the finger and nail abnormalities. The main oral aspects are midfacial hypoplasia, a grooved palate, and dental abnormalities include double row of teeth, delayed eruption of permanent dentition, multiple caries. Pathological fractures of the bones occur due to sclerosis. Radiologically, skull bones appear thickened with open fontanels which look like ‘lakes of bones’, hypoplasia of facial bones, generalized osteosclerosis, open fontanels and cranial sutures, non pneumotization of paranasal sinuses, and fractures commonly in lower limbs.
    [Show full text]
  • General Principles in the Assessment and Treatment of Nonunions
    General Principles in the Assessment and Treatment of Nonunions Jaimo Ahn, MD, PhD & Matthew Sullivan, MD Revised February 2017 Previous Authors: Peter Cole, MD; March 2004 Matthew J. Weresh, MD; Revised August 2006 Hobie Summers, MD & Daniel S. Chan MD; Revised April 2011 Definitions • Nonunion: (reasonably arbitrary) – A fracture that is not currently healed and is not going to • Delayed union: – A fracture that requires more time than usual to heal – Shows healing progress over time Definitions • Nonunion: A fracture that is a minimum of 9 months post occurrence and is not healed and has not shown radiographic progression for 3 months (FDA 1986) • Not pragmatic – Prolonged morbidity – Narcotic abuse – Professional and/or emotional impairment Definitions (pragmatic) • Nonunion: A fracture that has no potential to heal without further intervention All images unless indicated: Rockwood and Green's Fractures in Adults, 8th Edition 2015 Classification 1. Hypertrophic 2. Oligotrophic 3. Atrophic = Avascular 4. Pseudarthrosis Weber and Cech, 1976 Hypertrophic • Vascularized • Callus formation present on x-ray • “Elephant’s foot” - abundant callus • “Horse’s hoof” - less abundant callus Biology is more than sufficient but can’t consolidate likely need mechanically favorable solution Oligotrophic • Some/minimal callus on x-ray – Not an aggressive healing response, but not completely void of biologic activity • Vascularity is present on bone scan Is there sufficient biology / mechanics for healing? Atrophic • No evidence of callous formation
    [Show full text]
  • Osteopetrosis Associated with Familial Paraplegia: Report of a Family
    Paraplegia (1975), 13, 143-152 OSTEOPETROSIS ASSOCIATED WITH FAMILIAL PARAPLEGIA: REPORT OF A FAMILY By SKIP JACQUES*, M.D., JOHN T. GARNER, M. D., DAVID JOHNSON, M.D. and C. HUNTER SHELDEN, M. D. Departments of Neurosurgery and Radiology, Huntington Memorial Hospital, Pasadena, Ca., and the Huntington Institute of Applied Medical Research, Pasadena, Ca., U.S.A. Abstract. A clinical analysis of three members of a family with documented osteopetrosis and familial paraplegia is presented. All patients had a long history of increased bone density and slowly progressing paraparesis of both legs. A thorough review of the literature has revealed no other cases which presented with paraplegia without spinal cord com­ pression. Although the etiologic factor or factors remain unknown, our review supports the contention that this is a distinct clinical entity. IN 1904, a German radiologist, Heinrich Albers-Schonberg, described a 26-year­ old man with multiple fractures and generalised sclerosis of the skeleton. The disease has henceforth commonly been known as Albers-Schonberg disease or marble osteopetrosis, a term first introduced by Karshner in 1922. Other eponyms are bone disease, osteosclerosis fragilis generalisata, and osteopetrosis generalisata. Approximately 300 cases had been reported in the literature by 1968. It has been generally accepted that the disease presents in two distinct forms, an infantile progressive disease and a milder form in childhood and adolescence. The two forms differ clinically and genetically. A dominant pattern of inheritance is usually seen in the benign type whereas the severe infantile form is usually inherited as a Mendelian recessive. This important distinction has not been well emphasised.
    [Show full text]
  • Biochemical, Clinical and Genetic Characteristics in Adults with Persistent Hypophosphatasaemia; Data from an Endocrinological Outpatient Clinic in Denmark
    Bone Reports 15 (2021) 101101 Contents lists available at ScienceDirect Bone Reports journal homepage: www.elsevier.com/locate/bonr Biochemical, clinical and genetic characteristics in adults with persistent hypophosphatasaemia; Data from an endocrinological outpatient clinic in Denmark Nicola Hepp a,*, Anja Lisbeth Frederiksen b,c, Morten Duno d, Jakob Præst Holm e, Niklas Rye Jørgensen f,g, Jens-Erik Beck Jensen a,g a Dept. of Endocrinology, Hvidovre University Hospital Copenhagen, Kettegaard Alle 30, 2650 Hvidovre, Denmark b Dept. of Clinical Genetics, Aalborg University Hospital, Ladegaardsgade 5, 9000 Aalborg C, Denmark c Dept. of Clinical Research, Aalborg University, Fredrik Bajers Vej 7K, 9220 Aalborg Ø, Denmark d Dept. of Clinical Genetics, University Hospital Copenhagen Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark e Department of Endocrinology, Copenhagen University Hospital Herlev, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark f Dept. of Clinical Biochemistry, Rigshospitalet, Valdemar Hansens Vej 13, 2600 Glostrup, Denmark g Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3 B, 2200 Copenhagen, Denmark ARTICLE INFO ABSTRACT Keywords: Background: Hypophosphatasia (HPP) is an inborn disease caused by pathogenic variants in ALPL. Low levels of Alkaline phosphatase alkaline phosphatase (ALP) are a biochemical hallmark of the disease. Scarce knowledge about the prevalence of ALPL HPP in Scandinavia exists, and the variable clinical presentations make diagnostics challenging. The aim of this Hypophosphatasia study was to investigate the prevalence of ALPL variants as well as the clinical and biochemical features among Osteoporosis adults with endocrinological diagnoses and persistent hypophosphatasaemia. Bisphosphonates Methods: A biochemical database containing ALP measurements of 26,121 individuals was reviewed to identify adults above 18 years of age with persistently low levels of ALP beneath range (≤ 35 ± 2.7 U/L).
    [Show full text]
  • Nonunions: Evaluation 10022 and Treatment
    10022 CHAPTER 22 Nonunions: Evaluation 10022 and Treatment ......................................................... Mark R. Brinker, M.D. and Daniel P. O’Connor, Ph.D. a fracture that, in the opinion of the treating physician, s0010 INTRODUCTION shows slower progression to healing than anticipated and p0010 While fracture nonunions may represent a small percent- is at risk of nonunion without further intervention. age of the traumatologist’s case load, they can account for To understand the biological processes and clinical impli- p0070 a high percentage of a surgeon’s stress, anxiety, and frustra- cations of fracture nonunion, an understanding of the normal tion. Arrival of a fracture nonunion may be anticipated fracture healing process is required. The following section following a severe traumatic injury, such as an open fracture reviews the local biology of fracture healing, requirements with segmental bone loss, but may also appear following a for fracture union, and types of normal fracture repair. low-energy fracture that seemed destined to heal. p0020 Fracture nonunion is a chronic medical condition asso- FRACTURE REPAIR ciated with pain and functional and psychosocial disabil- s0030 180 ity. Because of the wide variation in patient responses Fracture repair is an astonishing process that involves p0080 to various stresses177 and the impact that may have on the spontaneous, structured regeneration of bony tissue and patient’s family (relationships, income, etc.), these cases restores mechanical stability. The process begins at the are often difficult to manage. moment of bony injury, initiating a proliferation of tissues p0030 Some 90 to 95 percent of all fractures heal without pro- that ultimately leads to healing.
    [Show full text]